Hepatic Hedgehog signaling contributes to the regulation of IGF1 and IGFBP1 serum levels

被引:47
|
作者
Matz-Soja, Madlen [1 ]
Aleithe, Susanne [1 ]
Marbach, Eugenia [1 ]
Boettger, Jan [1 ]
Arnold, Katrin [1 ]
Schmidt-Heck, Wolfgang [2 ]
Kratzsch, Juergen [3 ]
Gebhardt, Rolf [1 ]
机构
[1] Univ Leipzig, Fac Med, Inst Biochem, D-04109 Leipzig, Germany
[2] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany
[3] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04109 Leipzig, Germany
来源
CELL COMMUNICATION AND SIGNALING | 2014年 / 12卷
关键词
Gli3; Growth hormone; Hedgehog signaling; Hepatocytes; IGF-I; IGFBP-1; Liver; MotifMap; Patched1; Smoothened; GROWTH-FACTOR-I; FACTOR-BINDING PROTEIN-1; LIPID-METABOLISM; CRE RECOMBINASE; TRANSGENIC MICE; BODY GROWTH; LIVER; EXPRESSION; ZONATION; REVEALS;
D O I
10.1186/1478-811X-12-11
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Hedgehog signaling plays an important role in embryonic development, organogenesis and cancer. In the adult liver, Hedgehog signaling in non-parenchymal cells has been found to play a role in certain disease states such as fibrosis and cirrhosis. However, whether the Hedgehog pathway is active in mature healthy hepatocytes and is of significance to liver function are controversial. Findings: Two types of mice with distinct conditional hepatic deletion of the Smoothened gene, an essential co-receptor protein of the Hedgehog pathway, were generated for investigating the role of Hedgehog signaling in mature hepatocytes. The knockout animals (KO) were inconspicuous and healthy with no changes in serum transaminases, but showed a slower weight gain. The liver was smaller, but presented a normal architecture and cellular composition. By quantitative RT-PCR the downregulation of the expression of Indian hedgehog (Ihh) and the Gli3 transcription factor could be demonstrated in healthy mature hepatocytes from these mice, whereas Patched1 was upregulated. Strong alterations in gene expression were also observed for the IGF axis. While expression of Igf1 was downregulated, that of Igfbp1 was upregulated in the livers of both genders. Corresponding changes in the serum levels of both proteins could be detected by ELISA. By activating and inhibiting the transcriptional output of Hedgehog signaling in cultured hepatocytes through siRNAs against Ptch1 and Gli3, respectively, in combination with a ChIP assay evidence was collected indicating that Igf1 expression is directly dependent on the activator function of Gli3. In contrast, the mRNA level of Igfbp1 appears to be controlled through the repressor function of Gli3, while that of Igfbp2 and Igfbp3 did not change. Interestingly, body weight of the transgenic mice correlated well with IGF-I levels in both genders and also with IGFBP-1 levels in females, whereas it did not correlate with serum growth hormone levels. Conclusions: Our results demonstrate for the first time that Hedgehog signaling is active in healthy mature mouse hepatocytes and that it has considerable importance for IGF-I homeostasis in the circulation. These findings may have various implications for mouse physiology including the regulation of body weight and size, glucose homeostasis and reproductive capacity.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Hepatic Hedgehog signaling contributes to the regulation of IGF1 and IGFBP1 serum levels
    Madlen Matz-Soja
    Susanne Aleithe
    Eugenia Marbach
    Jan Böttger
    Katrin Arnold
    Wolfgang Schmidt-Heck
    Jürgen Kratzsch
    Rolf Gebhardt
    Cell Communication and Signaling, 12
  • [2] Black/white differences in IGFBP1 and IGF1 levels: Relationship to insulin secretion
    Bacha, F
    Saad, R
    Arslanian, S
    PEDIATRIC RESEARCH, 2002, 51 (04) : 121A - 121A
  • [3] IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort
    Verheus, Martijn
    Maskarinec, Gertraud
    Woolcott, Christy G.
    Haiman, Christopher A.
    Le Marchand, Loic
    Henderson, Brian E.
    Cheng, Iona
    Kolonel, Laurence N.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (05) : 1115 - 1123
  • [4] Serum IGF1 and IGFBP3 levels in SMA patients
    Kaymaz, A. Yesbek
    Bal, A.
    Bora-Tatar, G.
    Ozon, A.
    Alikasifoglu, A.
    Topaloglu, H.
    Erdem-Yurter, H.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S105 - S105
  • [5] Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk
    Terry, Kathryn L.
    Tworoger, Shelley S.
    Gates, Margaret A.
    Cramer, Daniel W.
    Hankinson, Susan E.
    CARCINOGENESIS, 2009, 30 (12) : 2042 - 2046
  • [6] Low IGF1 and high IGFBP1 predict diabetes onset in prediabetic patients
    Meyer, Nina M. T.
    Kabisch, Stefan
    Dambeck, Ulrike
    Honsek, Caroline
    Kemper, Margrit
    Gerbracht, Christiana
    Arafat, Ayman M.
    Birkenfeld, Andreas L.
    Schwarz, Peter E. H.
    Machann, Juergen
    Osterhoff, Martin A.
    Weickert, Martin O.
    Pfeiffer, Andreas F. H.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 187 (04) : 555 - 565
  • [7] Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample
    Voelzke, Henry
    Nauck, Matthias
    Rettig, Rainer
    Doerr, Marcus
    Higham, Claire
    Brabant, Georg
    Wallaschofski, Henri
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 161 (05) : 705 - 713
  • [8] A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among
    Schumacher, Fredrick R.
    Cheng, Iona
    Freedman, Matthew L.
    Mucci, Lorelei
    Allen, Naomi E.
    Pollak, Michael N.
    Hayes, Richard B.
    Stram, Daniel O.
    Canzian, Frederico
    Henderson, Brian E.
    Hunter, David J.
    Virtamo, Jarmo
    Manjer, Jonas
    Gaziano, J. Michael
    Kolonel, Laurence N.
    Tjonneland, Anne
    Albanes, Demetrius
    Calle, Eugenia E.
    Giovannucci, Edward
    Crawford, E. David
    Haiman, Christopher A.
    Kraft, Peter
    Willett, Walter C.
    Thun, Michael J.
    Marchand, Loic Le
    Kaaks, Rudolf
    Feigelson, Heather Spencer
    Bueno-de-Mesquita, H. Bas
    Palli, Domenico
    Riboli, Elio
    Lund, Eliv
    Amiano, Pilar
    Andriole, Gerald
    Dunning, Alison M.
    Trichopoulos, Dimitrios
    Stampfer, Meir J.
    Key, Timothy J.
    Ma, Jing
    HUMAN MOLECULAR GENETICS, 2010, 19 (15) : 3089 - 3101
  • [9] IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer
    Al-Zahrani, A
    Sandhu, MS
    Luben, RN
    Thompson, D
    Baynes, C
    Pooley, KA
    Luccarini, C
    Munday, H
    Perkins, B
    Smith, P
    Pharoah, PDP
    Wareham, NJ
    Easton, DF
    Ponder, BAJ
    Dunning, AM
    HUMAN MOLECULAR GENETICS, 2006, 15 (01) : 1 - 10
  • [10] Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with hypopituitarism during GH treatment: a randomized study
    Isotton, Ana Lucia
    Osorio Wender, Maria Celeste
    Casagrande, Alessandra
    Rollin, Guilherme
    Czepielewski, Mauro Antonio
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 166 (02) : 207 - 213